Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dhodapkar

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
Leukemia|December 2, 2005
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantationR L Comenzo, H Hassoun, T Kewalramani, et al.
The Journal of Experimental Medicine|May 16, 2007
Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response programKavita M Dhodapkar, Devi Banerjee, John Connolly, et al.
Journal of Shoulder and Elbow Surgery|August 18, 2024
Outcomes following total shoulder arthroplasty in patients with systemic lupus erythematosusAndrew Salib, Joshua G Sanchez, Lenique Huggins, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2005
Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cellsKavita M Dhodapkar, Jacob L Kaufman, Marc Ehlers, et al.
The Spine Journal : Official Journal of the North American Spine Society|November 4, 2024
Semaglutide utilization associated with reduced 90-day postoperative complications following single-level posterior lumbar fusion for patients with type II diabetesAnthony E Seddio, Michael J Gouzoulis, Rajiv S Vasudevan, et al.
The New England Journal of Medicine|November 24, 1999
Antitumor activity of thalidomide in refractory multiple myelomaS Singhal, J Mehta, R Desikan, et al.
Blood|October 16, 2015
Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathyMadhav V Dhodapkar, Rachael Sexton, Rituparna Das, et al.
Blood Advances|January 4, 2018
Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapyJithendra Kini Bailur, Sameet Mehta, Lin Zhang, et al.
North American Spine Society Journal|June 23, 2025
Postoperative complications in patients with sickle cell disease undergoing single-level anterior cervical discectomy and fusionGwyneth C Maloy, Rushabh H Doshi, Wesley Day, et al.
Blood|January 12, 2012
Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myelomaSrinivas Koduru, Ellice Wong, Till Strowig, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Leukemia|December 2, 2005
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantationR L Comenzo, H Hassoun, T Kewalramani, et al.
The Journal of Experimental Medicine|May 16, 2007
Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response programKavita M Dhodapkar, Devi Banerjee, John Connolly, et al.
Journal of Shoulder and Elbow Surgery|August 18, 2024
Outcomes following total shoulder arthroplasty in patients with systemic lupus erythematosusAndrew Salib, Joshua G Sanchez, Lenique Huggins, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2005
Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cellsKavita M Dhodapkar, Jacob L Kaufman, Marc Ehlers, et al.
The Spine Journal : Official Journal of the North American Spine Society|November 4, 2024
Semaglutide utilization associated with reduced 90-day postoperative complications following single-level posterior lumbar fusion for patients with type II diabetesAnthony E Seddio, Michael J Gouzoulis, Rajiv S Vasudevan, et al.
The New England Journal of Medicine|November 24, 1999
Antitumor activity of thalidomide in refractory multiple myelomaS Singhal, J Mehta, R Desikan, et al.
Blood|October 16, 2015
Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathyMadhav V Dhodapkar, Rachael Sexton, Rituparna Das, et al.
Blood Advances|January 4, 2018
Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapyJithendra Kini Bailur, Sameet Mehta, Lin Zhang, et al.
North American Spine Society Journal|June 23, 2025
Postoperative complications in patients with sickle cell disease undergoing single-level anterior cervical discectomy and fusionGwyneth C Maloy, Rushabh H Doshi, Wesley Day, et al.
Blood|January 12, 2012
Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myelomaSrinivas Koduru, Ellice Wong, Till Strowig, et al.
Pageof 16